DICE Therapeutics, Inc. (NASDAQ: DICE)
Some price data may be temporarily unavailable.
DICE Therapeutics, Inc. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DICE Therapeutics, Inc. Company Info
DICE Therapeutics, Inc.
News & Analysis
Featured Article
Why Dice Therapeutics Stock Bolted Higher This Week
The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.
George Budwell | Jun 22, 2023
Featured Article
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
The company received a buyout offer from Eli Lilly.
Jim Halley | Jun 20, 2023
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.